Literature DB >> 6167348

Analysis of surface proteins of mouse lung carcinomas using monoclonal antibodies.

S J Kennel, L J Foote, P K Lankford.   

Abstract

Hybridoma cultures secreting monoclonal antibodies were derived from fusions of parent myeloma P3-X63-Ag8 with spleen cells of F344 rats which had been immunized with the BALB/c alveolar lung carcinoma line 1. Screening of several thousand hybridoma cultures identified 55 cell lines making antibody that bound to the line 1 cell surface. Of 15 of these antibodies tested, seven could be identified as binding to P100, a surface protein expressed on both normal and tumor cells, and five reacted with a tumor surface protein with a molecular weight of 180,000 (TSP-180) not found on control cell lines. Monoclonal antibodies to TSP-180 bound to lung tumor cells but not to normal cells or tumors of other organs. Five different hybridoma cultures secreting antibody to TSP-180 were cloned, and monoclonal antibodies were purified by affinity chromatography. Radioiodinated monoclonal antibodies were used to determine affinity constants for binding to TSP-180 as it is expressed on four different mouse lung tumors. Binding constants ranged from 1.2 X 10(7) to 1.5 X 10(8) liters/mol for the different antibodies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167348

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Genetic analyses of integrin signaling.

Authors:  Sara A Wickström; Korana Radovanac; Reinhard Fässler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

2.  Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells.

Authors:  A Sacchi; G Piaggio; M A Rizzo; R Falcioni; S J Kennel
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

Review 3.  Human tumor-associated antigens identified by monoclonal antibodies.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Springer Semin Immunopathol       Date:  1982

Review 4.  Molecular lesions in cancer.

Authors:  H Busch
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

5.  Discrimination of lesion removal of N-methylpurine-DNA glycosylase revealed by a potent neutralizing monoclonal antibody.

Authors:  Sanjay Adhikari; Stephen J Kennel; Gargi Roy; Partha S Mitra; Sankar Mitra; Rabindra Roy
Journal:  DNA Repair (Amst)       Date:  2007-09-04

6.  Metastatic dissemination of 3LL variants after treatment with monoclonal antibody to a tumor-associated antigen.

Authors:  A Sacchi; S Kennel; P G Natali; G Tibursi; C A Ghetti
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

7.  Monoclonal antibodies to the murine VLA-6 alpha-chain trigger homotypic lymphocyte aggregation.

Authors:  R P Wuthrich
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

8.  Retinoic acid negatively regulates beta 4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line.

Authors:  C Gaetano; A Melchiori; A Albini; R Benelli; R Falcioni; A Modesti; A Modica; S Scarpa; A Sacchi
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

9.  Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.

Authors:  A Mori; S J Kennel; M van Borssum Waalkes; G L Scherphof; L Huang
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer.

Authors:  Yu-Ling Tai; Pei-Yu Chu; I-Rue Lai; Ming-Yang Wang; Hui-Yuan Tseng; Jun-Lin Guan; Jun-Yang Liou; Tang-Long Shen
Journal:  Sci Rep       Date:  2015-11-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.